ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Alpha Cognition Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.50+0.31 (+3.79%)
Close on Oct 19, 2026
- Market cap
- $185.08M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Mar 26, 2026 | After market close | $2.50M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 13, 2024 | After market close | – | $-0.01 | – |
Press releases
Announcements Alpha Cognition filed with the SEC
NOTICE OF MEETING AND RECORD DATE DATED MARCH 27, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ANNOUNCES FINANCIAL RESULTS FOR THE 2025 FISCAL YEAR DATED MARCH 26, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ANNOUNCING OFFERING, DATED SEPTEMBER 30, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ANNOUNCING PRICING OF OFFERING, DATED SEPTEMBER 30, 2025
Material agreement · Other events · EX-99.2 to Form 8-K
MANAGEMENT INFORMATION CIRCULAR DATED AUGUST 21, 2024
Other events · EX-99.1 to Form 8-K
NOTICE OF ANNUAL GENERAL MEETING
Other events · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Other events · EX-99.3 to Form 8-K
PRESS RELEASE DATED AUGUST 12, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 29, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K